Posts by: Margarida Azevedo, MSc

Margarida Azevedo, MSc

Margarida graduated with a BS in Health Sciences from the University of Lisbon and a MSc in Biotechnology from Instituto Superior Técnico (IST-UL). She worked as a molecular biologist research associate at a Cambridge UK-based biotech company that discovers and develops therapeutic, fully human monoclonal antibodies.

February 24, 2016February 24, 2016

Fibromyalgia Study Finds Paroxetine Best of Newer Antidepressants to Combine with Drug Treatment

News

The combined use of pregabalin and the antidepressant paroxetine is more effective in reducing somatic symptoms and depression in fibromyalgia patients than pregabalin with other relatively new antidepressants, showing both better efficacy and tolerability and reduced side effects, according to ... Read more

February 22, 2016May 19, 2016

Leading Pain Genetics Study Presented by Proove Biosciences at AAPM 2016

News

Proove Biosciences Inc., a company that specializes in research for tailored pain medicine, has presented results from three studies on the link between genetics and pain at this year’s American Academy of ... Read more

February 17, 2016February 17, 2016

Fibromyalgia Pain May Be Eased by Personalized Acupuncture

News

Individualized acupuncture treatments given to fibromyalgia patients in a primary care setting provided effective pain relief and an enhanced quality of life, with effects persisting for a year, a study, published in ... Read more

February 15, 2016February 15, 2016

Pain Relief Evident in Type of MRI Scan Could Aid Drug Development

News

Functional magnetic resonance imaging (FMRI) measures of the brain’s neural response to pain may be a viable tool for evaluating the effectiveness of new pain medications under development, according to the study ... Read more

February 11, 2016February 11, 2016

Fibromyalgia Pain, Fatigue Ably Treated with Mind Body Therapies, Review Finds

News

Mind body therapies (MBTs) are promising therapeutic approaches for chronic rheumatic diseases, including fibromyalgia syndrome (FMS), and improve both mental and physical health, according to a review titled “Mind body therapies in ... Read more

February 8, 2016May 19, 2016

Tonix to Discuss Fibromyalgia Study Results at BIO CEO & Investor Meet

News

Tonix Pharmaceuticals Holding Corp., a company developing next-generation therapeutics for fibromyalgia, episodic tension-type headaches, and post-traumatic stress disorder (PTSD), is among the participants at the 18th annual BIO CEO & Investor ... Read more

February 4, 2016February 4, 2016

Fibromyalgia Patients Get Help With New Self-Report Measure of Fatigue

News

Researchers have created a new self-report measure of fatigue for fibromyalgia patients, the Patient-Reported Outcomes Measurement Information System (PROMIS) Fatigue Profile. The research paper, “The PROMIS Fatigue Profile: a self-report measure of ... Read more

February 3, 2016February 3, 2016

Stressful Events, Pain Are Key Issues in Fibromyalgia Patients

News

In a study titled “Evaluation of the accuracy of several symptoms and domains in distinguishing patients diagnosed with fibromyalgia from healthy controls,” published in the journal Clinical and Experimental Rheumatology, researchers found ... Read more

February 1, 2016February 1, 2016

Acupuncture Does Not Appear to Relieve Pain in Fibromyalgia Patients

News

Acupuncture, along with two other alternative methods of pain relief, proved to be insufficient to provide the analgesia needed for patients with fibromyalgia. These are the results of a study titled ... Read more

January 29, 2016January 29, 2016

Melbourne Wellness Clinic Recruiting Patients for Fibromyalgia Flotation Therapy Study

News

Inner Outer Health, a health and wellness clinic in Melbourne, is enrolling Australian fibromyalgia patients to test its non-invasive alternative treatment, called REST (Restricted Environmental Stimulation Therapy) flotation therapy. Fibromyalgia is ... Read more